| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |